Free Trial

Nomura Holdings, Inc. (NYSE:NMR) Shares Sold by Cresset Asset Management LLC

Nomura logo with Finance background

Cresset Asset Management LLC reduced its stake in Nomura Holdings, Inc. (NYSE:NMR - Free Report) by 80.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 12,358 shares of the financial services provider's stock after selling 50,519 shares during the quarter. Cresset Asset Management LLC's holdings in Nomura were worth $72,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. R Squared Ltd purchased a new stake in Nomura in the 4th quarter valued at $26,000. Adero Partners LLC purchased a new stake in Nomura in the 4th quarter valued at $59,000. Savant Capital LLC purchased a new stake in Nomura in the 4th quarter valued at $59,000. Cannell & Spears LLC purchased a new stake in Nomura in the 4th quarter valued at $73,000. Finally, Cubist Systematic Strategies LLC purchased a new stake in Nomura in the 4th quarter valued at $84,000. 15.14% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen cut Nomura from a "buy" rating to a "hold" rating in a report on Monday, April 28th.

Check Out Our Latest Stock Analysis on NMR

Nomura Trading Up 0.3%

Shares of NYSE NMR traded up $0.02 during mid-day trading on Thursday, reaching $5.98. 307,139 shares of the company's stock were exchanged, compared to its average volume of 741,586. The firm has a market capitalization of $17.75 billion, a price-to-earnings ratio of 8.54, a PEG ratio of 0.30 and a beta of 0.77. The company has a debt-to-equity ratio of 7.52, a quick ratio of 1.11 and a current ratio of 1.17. Nomura Holdings, Inc. has a 52-week low of $4.66 and a 52-week high of $6.99. The company's 50-day moving average is $5.79 and its 200-day moving average is $6.02.

Nomura (NYSE:NMR - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The financial services provider reported $0.15 earnings per share for the quarter, missing analysts' consensus estimates of $0.18 by ($0.03). The business had revenue of $7.08 billion for the quarter, compared to analysts' expectations of $451.20 billion. Nomura had a return on equity of 9.19% and a net margin of 7.96%. Analysts expect that Nomura Holdings, Inc. will post 0.76 EPS for the current fiscal year.

Nomura Profile

(Free Report)

Nomura Holdings, Inc provides various financial services to individuals, corporations, financial institutions, governments, and governmental agencies worldwide. It operates through three segments: Retail, Investment Management, and Wholesale. The Retail segment offers various financial products and investment consultation services.

Further Reading

Institutional Ownership by Quarter for Nomura (NYSE:NMR)

Should You Invest $1,000 in Nomura Right Now?

Before you consider Nomura, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nomura wasn't on the list.

While Nomura currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines